DNA FY 2025 Earnings — Ginkgo Bioworks Holdings, Inc. Revenue & Financial Results | Market Cap Arena

DNAGinkgo Bioworks Holdings, Inc.

$418M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$170M-25.1% YoY

Gross Profit

$139M81.5% margin

Operating Income

-$315M-185.3% margin

Net Income

-$313M-183.8% margin

EPS (Diluted)

$-5.64

Cash Flow

Operating Cash Flow

-$171M

Free Cash Flow

-$179M

Stock-Based Comp.

$82M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$611M

Stockholders' Equity

$509M

Cash & Equivalents

$167M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$170M	$227M	-25.1%
Gross Profit	$139M	$188M	-26.5%
Operating Income	-$315M	-$560M	+43.7%
Net Income	-$313M	-$547M	+42.8%